-
1Periodical
Authors: Braal, C. Louwrens, Hussaarts, Koen G. A. M., Seuren, Lieke, Oomen-de Hoop, Esther, de Bruijn, Peter, Buck, Stefan A. J., Bos, Monique E. M. M., Thijs-Visser, Martine F., Zuetenhorst, Hanneke J. M., Mathijssen-van Stein, Daniëlle, Vastbinder, Mijntje B., van Leeuwen, Roelof W. F., van Gelder, Teun, Koolen, Stijn L. W., Jager, Agnes, Mathijssen, Ron H. J.
Source: Breast cancer research and treatment. 184(1):107-113
-
2Academic Journal
Authors: Buck, Stefan A. J., Talebi, Zahra, Drabison, Thomas, Jin, Yan, Gibson, Alice A., Hu, Peng, de Bruijn, Peter, de Ridder, Corrina M. A., Stuurman, Debra, Hu, Shuiying, van Weerden, Wytske M., Koolen, Stijn L. W., de Wit, Ronald, Sparreboom, Alex, Mathijssen, Ron H. J., Eisenmann, Eric D.
Source: International Journal of Cancer; Jul2024, Vol. 155 Issue 2, p314-323, 10p
Subject Terms: DOCETAXEL, ANDROGEN receptors, PROSTATE cancer patients, DRUG interactions
-
3Academic Journal
Authors: Guchelaar, Niels A. D.1 (AUTHOR) n.guchelaar@erasmusmc.nl, Buck, Stefan A. J.1 (AUTHOR), van Doorn, Leni1 (AUTHOR), Hussaarts, Koen G. A. M.1 (AUTHOR), Sandberg, Yorick2 (AUTHOR), van der Padt-Pruijsten, Annemieke1,2 (AUTHOR), van Alphen, Robbert J.3 (AUTHOR), Poppe-Manenschijn, Laura4 (AUTHOR), Vleut, Isolde5 (AUTHOR), de Bruijn, Peter1 (AUTHOR), van Leeuwen, Roelof W. F.5 (AUTHOR), Mostert, Bianca1 (AUTHOR), Eskens, Ferry A. L. M.1 (AUTHOR), Oomen-de Hoop, Esther1 (AUTHOR), Koolen, Stijn L. W.1,5 (AUTHOR), Mathijssen, Ron H. J.1 (AUTHOR)
Source: Clinical Pharmacokinetics. Jul2024, Vol. 63 Issue 7, p1037-1044. 8p.
Subject Terms: *IRINOTECAN, *REGORAFENIB, *METFORMIN, *ORGANIC cation transporters, *CIMETIDINE, *PHARMACOKINETICS, *BONFERRONI correction, *DRUG interactions
-
4Academic Journal
Authors: Buijs, Sanne M., Braal, C. Louwrens, Buck, Stefan A. J., van Maanen, Noud F., van der Meijden-Erkelens, Lonneke M., Kuijper-Tissot van Patot, Heleen A., Hoop, Esther Oomen-de, Saes, Lotte, van den Boogerd, Sophia J., Struik, Liesbeth E. M., van Rossum-Schornagel, Quirine C., Mathijssen, Ron H. J., Koolen, Stijn L. W., Jager, Agnes
Source: NPJ Breast Cancer; 8/5/2023, Vol. 9 Issue 1, p1-7, 7p
-
5Academic Journal
Authors: Li, Yang, Jin, Yan, Taheri, Hanieh, Schmidt, Keith T., Gibson, Alice A., Buck, Stefan A. J., Eisenmann, Eric D., Mathijssen, Ron H. J., Figg, William D., Baker, Sharyn D., Sparreboom, Alex, Hu, Shuiying
Source: Pharmaceutics; Sep2022, Vol. 14 Issue 9, pN.PAG-N.PAG, 15p
Subject Terms: DRUG interactions, PACLITAXEL, METABOLOMICS, BILE acids, BIOMARKERS, RIFAMPIN, FORECASTING
-
6Academic Journal
Authors: Buck, Stefan A. J., Braal, C. Louwrens, Hofman, Maaike M., Oomen-de Hoop, Esther, Bruijn, Peter de, Ghobadi Moghaddam-Helmantel, Inge M., Hussaarts, Koen G. A. M., Vastbinder, Mijntje B., van Rossum-Schornagel, Quirine C., van Schaik, Ron H. N., Jager, Agnes, Koolen, Stijn L. W., Mathijssen, Ron H. J.
Source: Therapeutic Advances in Medical Oncology; 3/17/2022, p1-8, 8p
-
7Academic Journal
Authors: Buck, Stefan A. J.1 (AUTHOR) s.buck@erasmusmc.nl, Guchelaar, Niels A. D.1 (AUTHOR), de Bruijn, Peter1 (AUTHOR), Ghobadi Moghaddam-Helmantel, Inge M.1 (AUTHOR), Oomen-de Hoop, Esther1 (AUTHOR), Westgeest, Hans M.2 (AUTHOR), Hamberg, Paul3 (AUTHOR), Mathijssen-van Stein, Danielle3 (AUTHOR), Lolkema, Martijn P.1 (AUTHOR), Koolen, Stijn L. W.1,4 (AUTHOR), de Wit, Ronald1 (AUTHOR), Mathijssen, Ron H. J.1 (AUTHOR)
Source: Clinical Pharmacokinetics. Oct2022, Vol. 61 Issue 10, p1471-1473. 3p.
Subject Terms: *ANTIANDROGENS, *HETEROCYCLIC compounds, *HYDROCARBONS
-
8Academic Journal
Authors: Braal, C. Louwrens, Hussaarts, Koen G. A. M., Seuren, Lieke, Oomen‑deHoop, Esther, de Bruijn, Peter, Buck, ·Stefan A. J., Bos, Monique E. M. M., Thijs‑Visser, Martine F., Zuetenhorst, Hanneke J. M., Mathijssen‑van Stein, Daniëlle, Vastbinder, Mijntje B., van Leeuwen, Roelof W. F., van Gelder, Teun, Koolen, Stijn L. W., Jager, Agnes, Mathijssen, Ron H. J.
Source: Breast Cancer Research & Treatment; Feb2021, Vol. 185 Issue 3, p889-889, 1p
-
9Academic Journal
This result is not displayed to guests.
Login for full access.